好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2016 Annual Meeting | Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease

Saturday 04/16/16
06:30 PM - 09:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Case Studies Program
Anne M. Connolly, MD, FAAN
Participants should be familiar with the differential diagnosis, evaluation, treatment, and management of common and uncommon neuromuscular disorders, and gain an enhanced awareness of rare or unusual neuromuscular phenotypes.
3.00 CME credits
Trainee, General Neurologist, Specialist Neurologist
Case-based, Interactive, Audience Participation
Event Timeline
06:30 PM - 09:30 PM Neuromuscular Case Studies
Muhammad Al-Lozi, MD, Anne M. Connolly, MD, FAAN, P. James B. Dyck, MD, FAAN
06:30 PM - 09:30 PM
06:30 PM - 09:30 PM
Faculty Disclosures
Anne M. Connolly, MD, FAAN Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Connolly has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. The institution of Dr. Connolly has received research support from Muscular Dystrophy Association. The institution of Dr. Connolly has received research support from NIH.
Muhammad Al-Lozi, MD Dr. Al-Lozi has nothing to disclose.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.